READY: REAl-world Data from an Italian compassionate use program of avelumab first-line maintenance for locallY advanced or metastatic urothelial carcinoma

Autor: Antonuzzo, L., Maruzzo, M., De Giorgi, U., Santini, D., Tambaro, R., Buti, S., Carrozza, F., Calabrò, F., Di Lorenzo, G., Fornarini, G., Iacovelli, R., Cullurà, D., Messina, C., Cerbone, L., Fazzi, G., Venturini, F., Colasanto, R., Necchi, A., Bracarda, S.

Publikováno v: In ESMO Real World Data and Digital Oncology September 2024 5

Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies

Autor: Altavilla, Amelia, Atzori, Francesco, Banna, Giuseppe Luigi, Barni, Sandro, Basso, Umberto, Bauckneht, Matteo, Berardi, Rossana, Berruti, Alfredo, Bertoldo, Francesco, Bimbatti, Davide, Boccardo, Francesco, Buti, Sebastiano, Buttigliero, Consuelo, Caffo, Orazio, Calabrò, Fabio, Cattrini, Carlo, Cellini, Francesco, Conteduca, Vincenza, Cursano, Maria Concetta, De Feo, Giulia, De Giorgi, Ugo, Di Lorenzo, Giuseppe, Di Maio, Massimo, Di Napoli, Marilena, Ermacora, Paola, Fornarini, Giuseppe, Fratino, Lucia, Fusco, Vittorio, Gernone, Angela, Ibrahim, Toni, Lanzetta, Gaetano, Malgeri, Andrea, Maruzzo, Marco, Masini, Cristina, Messina, Carlo, Mosca, Alessandra, Naglieri, Emanuele, Nolè, Franco, Ortega, Cinzia, Palermo, Andrea, Pantano, Francesco, Prati, Veronica, Procopio, Giuseppe, Rescigno, Pasquale, Roberto, Michela, Rossetti, Sabrina, Roviello, Giandomenico, Santini, Daniele, Stellato, Marco, Tambaro, Rosa, Toma, Ilaria, Tucci, Marcello, Valsecchi, Anna Amela, Verzoni, Elena, Zanardi, Elisa, Zucali, Paolo Andrea, Cursano, M.C., Valsecchi, A.A., Pantano, F., Di Maio, M., Procopio, G., Berruti, A., Bertoldo, F., Tucci, M., De Giorgi, U., Santini, D.

Publikováno v: In ESMO Open July 2024 9(7)

Efficacy and safety of high-dose chemotherapy as the first or subsequent salvage treatment line in patients with relapsed or refractory germ cell cancer: an international multicentric analysis

Autor: Seidel, C., Schaefers, C., Connolly, E.A., Weickhardt, A., Grimison, P., Wong, V., De Giorgi, U., Hentrich, M., Zschäbitz, S., Ochsenreither, S., Vincenzi, B., Oing, C., Bokemeyer, C., Engel, N., Alsdorf, W., Tran, B.

Publikováno v: In ESMO Open May 2024 9(5)

Longitudinal assessment of plasma androgen receptor copy number predicts overall survival in subsequent treatment lines in castration-resistant prostate cancer: analysis from a prospective trial

Autor: Brighi, N., Conteduca, V., Gurioli, G., Scarpi, E., Cursano, M.C., Bleve, S., Lolli, C., Schepisi, G., Casadei, C., Gianni, C., Ulivi, P., De Giorgi, U.

Publikováno v: In ESMO Open December 2023 8(6)

Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2 ^EV Study.

Autor: Fiala O; Department of Oncology and Radiotherapeutics, Faculty of Medicine, University Hospital in Pilsen, Charles University, alej Svobody 80, 30460, Pilsen, Czech Republic. fialao@fnplzen.cz.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. fialao@fnplzen.cz., Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy., Basso U; Medical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, 35128, Padova, Italy., Giannatempo P; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian 1, Milan, Italy., Grande E; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain., Buti S; Department of Medicine and Surgery, University of Parma, Parma, Italy.; Medical Oncology Unit, University Hospital of Parma, Parma, Italy., Myint ZW; Division of Medical Oncology, Department of Internal Medicine, Markey Cancer Center, University of Kentucky, Lexington, KY, USA., De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Pichler R; Department of Urology, Medical University of Innsbruck, Innsbruck, Austria., Grillone F; Unità Operativa di Oncologia Presidio Pugliese-Ciaccio Azienda Ospedaliera Universitaria Renato Dulbecco, Catanzaro, Italy., Ürün Y; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey., Calabrò F; Medical Oncology, 1-IRCCS Regina Elena National Cancer Institute, Rome, Italy., Bourlon MT; Department of Hemato-Oncology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.; Escuela de Medicina, Universidad Panamericana, Mexico City, Mexico., Galli L; Medical Oncology Unit 2, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy., Kanesvaran R; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Roviello G; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Viale Pieraccini, 6, Florence, Italy., Kucharz J; Department of Uro-Oncology, Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Warsaw, Poland., Rizzo M; Medical Oncology Unit, Azienda Ospedaliera Universitaria Consorziale Policlinico di Bari, Bari, Italy., Park SH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Cerbone L; Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy., Seront E; Department of Medical Oncology, Cliniques Universitaires Saint-Luc, Brussels, Belgium., Messina C; Oncology Unit, A.R.N.A.S. Civico, Palermo, Italy., Molina-Cerrillo J; Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain., Santini D; Oncologia, Dip, Scienze e Biotecnologie Medico-chirurgiche, Policlinico Umberto 1, Rome, Italy., Yano A; Department of Urology, Saitama Medical Center, Saitama Medical University, Saitama, Japan., Incorvaia L; Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), Section of Medical Oncology, University of Palermo, Palermo, Italy., Catalano M; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Pinto A; Servicio de Oncología, Hospital Universitario La Paz, Madrid, Spain., Formisano L; Department of Medicine and Surgery, Federico II University, Naples, Italy., Soares A; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.; Centro Paulista de Oncologia/Oncoclínicas, São Paulo, SP, Brazil., Facchini G; Oncology Unit, 'S. Maria Delle Grazie' Hospital, ASL NA2 NORD, Pozzuoli, Naples, Italy., Fornarini G; IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Poprach A; Masaryk Memorial Cancer Institute, Brno, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, Czech Republic., Rebuzzi SE; Medical Oncology Unit, Ospedale San Paolo, Savona, Italy.; Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genoa, Genoa, Italy., Nasso C; Medical Oncology, Ospedale Santa Corona, Pietra Ligure, Italy., Spinelli GP; UOC Oncologia Territoriale Ausl Latina, Aprilia, Italy., Angel M; Clinical Oncology, Genitourinary Oncology Unit, Alexander Fleming Institute, Buenos Aires, Argentina., Stellato M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian 1, Milan, Italy., Tural D; Department of Medical Oncology, Bakirköy Dr. SadiKonuk Training and Research Hospital, Tevfik, Bakirkoy, Istanbul, Turkey., Aurilio G; Division of Cancer Prevention and Genetics, IEO European Institute of Oncology IRCCS, Milan, Italy., Epstein I; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Carrozza F; Oncology Unit, Department of Oncology and Hematology, Santa Maria delle Croci Hospital, AUSL Romagna, Ravenna, Italy., Monteiro FSM; Hospital Sírio-Libanês, Brasília, DF, Brazil.; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil., Benedetti G; U.O. Oncologia, Ospedale di Civitanova Marche, Civitanova Marche, Italy., Büchler T; Department of Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic., Ortega C; Dipartimento di Oncologia, Ospedale San Lazzaro, Azienda sanitaria locale CN2, Alba, Cuneo, Italy., Zakopoulou R; 2nd Propaedeutic Department of Internal Medicine, School of Medicine, ATTIKON University Hospital, National and Kapodistrian University of Athens, Athens, Greece., Battelli N; Medical Oncology Unit, Macerata Hospital, Macerata, Italy., Porta C; Interdisciplinary Department of Medicina, Division of Medical Oncology, University of Bari 'Aldo Moro', A.O.U. Consorziale Policlinico di Bari, Bari, Italy., Bellmunt J; Harvard Medical School, Boston, MA, USA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Gupta S; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Santoni M; Medical Oncology Unit, Macerata Hospital, Macerata, Italy.

Publikováno v: Targeted oncology [Target Oncol] 2024 Nov; Vol. 19 (6), pp. 905-915. Date of Electronic Publication: 2024 Oct 01.